Suppr超能文献

C1q 肾病伴塌陷是另一种 MYH9 相关肾脏疾病吗?一例报告。

Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.

机构信息

Department of Internal Medicine-Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.

出版信息

Am J Kidney Dis. 2010 May;55(5):e21-4. doi: 10.1053/j.ajkd.2009.10.060. Epub 2010 Jan 29.

Abstract

C1q nephropathy is a rare kidney disease that can present with nephrotic syndrome and typically has the histologic phenotype of either minimal change disease or focal segmental glomerulosclerosis (FSGS). Disagreement exists about whether it is a distinct immune complex-mediated glomerulopathy or it resides in the spectrum of FSGS-minimal change disease. Two African American patients with C1q nephropathy histologically presenting as the collapsing variant of FSGS (collapsing C1q nephropathy) and rapid loss of kidney function were genotyped for polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9). Both cases were homozygous for the MYH9 E1 risk haplotype, the variant strongly associated with idiopathic FSGS, collapsing FSGS in human immunodeficiency virus-associated nephropathy, and focal global glomerulosclerosis (historically attributed to hypertensive nephrosclerosis). Collapsing C1q nephropathy with rapid progression to end-stage renal disease appears to reside in the MYH9-associated disease spectrum.

摘要

C1q 肾病是一种罕见的肾脏疾病,可表现为肾病综合征,其组织学表型通常为微小病变性疾病或局灶节段性肾小球硬化症(FSGS)。关于它是否是一种独特的免疫复合物介导的肾小球病,还是存在于 FSGS-微小病变病谱中,存在争议。两名患有 C1q 肾病的非裔美国患者,其组织学表现为 FSGS 的塌陷变体(塌陷性 C1q 肾病),且肾功能迅速丧失,对非肌肉肌球蛋白重链 9 基因(MYH9)的多态性进行了基因分型。两种情况均为 MYH9 E1 风险单倍型纯合子,该变体与特发性 FSGS、人类免疫缺陷病毒相关性肾病中的塌陷 FSGS 和局灶性全球肾小球硬化症(历史上归因于高血压性肾病)强烈相关。进展迅速至终末期肾病的塌陷性 C1q 肾病似乎存在于与 MYH9 相关的疾病谱中。

相似文献

1
Is collapsing C1q nephropathy another MYH9-associated kidney disease? A case report.
Am J Kidney Dis. 2010 May;55(5):e21-4. doi: 10.1053/j.ajkd.2009.10.060. Epub 2010 Jan 29.
3
Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.
Hum Mol Genet. 2010 May 1;19(9):1805-15. doi: 10.1093/hmg/ddq039. Epub 2010 Feb 2.
6
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
Nat Genet. 2008 Oct;40(10):1175-84. doi: 10.1038/ng.226. Epub 2008 Sep 14.
7
MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?
Semin Nephrol. 2010 Jul;30(4):409-17. doi: 10.1016/j.semnephrol.2010.06.007.
9
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy.
J Am Soc Nephrol. 2011 Nov;22(11):1991-6. doi: 10.1681/ASN.2011040434. Epub 2011 Oct 13.

引用本文的文献

1
APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
Am J Kidney Dis. 2018 Nov;72(5 Suppl 1):S8-S16. doi: 10.1053/j.ajkd.2018.06.020.
2
Apolipoprotein L1 Gene Effects on Kidney Transplantation.
Semin Nephrol. 2017 Nov;37(6):530-537. doi: 10.1016/j.semnephrol.2017.07.006.
3
[Advances in clinical research on C1q nephropathy].
Zhongguo Dang Dai Er Ke Za Zhi. 2016 Nov;18(11):1194-1198. doi: 10.7499/j.issn.1008-8830.2016.11.027.
4
MYH9 nephropathy.
Kidney Res Clin Pract. 2015 Mar;34(1):53-6. doi: 10.1016/j.krcp.2014.09.003. Epub 2014 Nov 28.
5
Genetic variation and adaptation in Africa: implications for human evolution and disease.
Cold Spring Harb Perspect Biol. 2014 Jul 1;6(7):a008524. doi: 10.1101/cshperspect.a008524.
6
The new era of APOL1-associated glomerulosclerosis.
Nephrol Dial Transplant. 2012 Apr;27(4):1288-91. doi: 10.1093/ndt/gfr812. Epub 2012 Feb 2.
7
Target organ damage in African American hypertension: role of APOL1.
Curr Hypertens Rep. 2012 Feb;14(1):21-8. doi: 10.1007/s11906-011-0237-4.
8
Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
Nephrol Dial Transplant. 2011 Nov;26(11):3805-10. doi: 10.1093/ndt/gfr542. Epub 2011 Sep 19.
9
Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
PLoS Genet. 2011 Jun;7(6):e1002150. doi: 10.1371/journal.pgen.1002150. Epub 2011 Jun 16.
10
The non-muscle Myosin heavy chain 9 gene (MYH9) is not associated with lupus nephritis in African Americans.
Am J Nephrol. 2010;32(1):66-72. doi: 10.1159/000314688. Epub 2010 Jun 7.

本文引用的文献

3
Genome-wide linkage analysis of serum creatinine in three isolated European populations.
Kidney Int. 2009 Aug;76(3):297-306. doi: 10.1038/ki.2009.135. Epub 2009 Apr 22.
5
MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.
Nat Genet. 2008 Oct;40(10):1175-84. doi: 10.1038/ng.226. Epub 2008 Sep 14.
6
MYH9 is associated with nondiabetic end-stage renal disease in African Americans.
Nat Genet. 2008 Oct;40(10):1185-92. doi: 10.1038/ng.232. Epub 2008 Sep 14.
7
A new multipoint method for genome-wide association studies by imputation of genotypes.
Nat Genet. 2007 Jul;39(7):906-13. doi: 10.1038/ng2088. Epub 2007 Jun 17.
8
C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Kidney Int. 2003 Oct;64(4):1232-40. doi: 10.1046/j.1523-1755.2003.00218.x.
9
Collapsing glomerulopathy.
Semin Nephrol. 2003 Mar;23(2):209-18. doi: 10.1053/snep.2003.50019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验